Cargando…
A closer look at rituximab induction on HLA antibody rebound following HLA incompatible kidney transplantation
Rituximab has been used to increase the efficacy of desensitization protocols for HLA incompatible kidney transplantation, however, controlled comparisons have not been reported. Here we examined 256 post-transplant HLA antibody levels in 25 recipients desensitized with or 25 without rituximab induc...
Autores principales: | Jackson, Annette M., Kraus, Edward S., Orandi, Babak J., Segev, Dorry L., Montgomery, Robert A., Zachary, Andrea A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305036/ https://www.ncbi.nlm.nih.gov/pubmed/25054778 http://dx.doi.org/10.1038/ki.2014.261 |
Ejemplares similares
-
Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation
por: Motter, Jennifer D., et al.
Publicado: (2023) -
Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation
por: Noble, Johan, et al.
Publicado: (2021) -
Successful ABO and HLA incompatible kidney transplantation in children in the UK
por: Hew, Eun Yee, et al.
Publicado: (2022) -
HLA-C Incompatibilities in Allogeneic Unrelated Hematopoietic Stem Cell Transplantation
por: Tiercy, Jean-Marie
Publicado: (2014) -
Acute Rejection and Infectious Complications in ABO- and HLA-Incompatible Kidney Transplantations
por: Ko, Youngmin, et al.
Publicado: (2020)